Alpha Fetoprotein (Amniotic Fluid) with Reflex to Acetylcholinesterase and Fetal Hemoglobin
Evaluate possibility of a fetal open neural tube defect at 13-36 weeks of gestation.
Quantitative Chemiluminescent Immunoassay/Electrophoresis
Reflex: 3-11 days
New York DOH Approval Status
Amniocentesis. Specimen must be drawn between 13 weeks, 0 days and 36 weeks, 6 days gestation.
Transport 2.5 mL amniotic fluid. (Min: 1.5 mL)
Submit with Order: Gestational age at time of collection or estimated due date.
Ambient: 1 month; Refrigerated: 3 months; Frozen: 3 months
|AFP, AF MoM||≤1.99|
Refer to report.
This test was developed and its performance characteristics determined by ARUP Laboratories. It has not been cleared or approved by the US Food and Drug Administration. This test was performed in a CLIA certified laboratory and is intended for clinical purposes.
Information must include weeks of gestation. If the AFP (amniotic fluid) is elevated, then Acetylcholinesterase will be added. Additional charges apply. Acetylcholinesterase testing requires an additional 3-11 days to be reported.
82106; if reflexed, add 82013 and 83033
|Component Test Code*||Component Chart Name||LOINC|
|0080015||AFP, Amniotic Fluid||1832-5|
|0080929||AFP AF Interpretation||41273-4|
|3000162||AFP, AF MoM||29595-6|
|3000263||Gestational Age Calculated at Collection||18185-9|
- AFP-AF (Alpha-Fetoprotein, Amniotic Fluid)
- Alpha Fetoprotein, Amniotic Fluid
- Alpha-Fetoprotein, Amniotic Fluid
- Fetoprotein, Amniotic Fluid